HPR31 Impact of Telehealth Use during the COVID-19 Pandemic on Glycemic Control and Other Biomarkers Among Type 2 Diabetes Patients

Detalles Bibliográficos
Autores principales: Shao, Y, Shi, L, Nauman, E, Price-Haywood, E, Stoecker, C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232787/
http://dx.doi.org/10.1016/j.jval.2022.04.957
_version_ 1784735672908644352
author Shao, Y
Shi, L
Nauman, E
Price-Haywood, E
Stoecker, C
author_facet Shao, Y
Shi, L
Nauman, E
Price-Haywood, E
Stoecker, C
author_sort Shao, Y
collection PubMed
description
format Online
Article
Text
id pubmed-9232787
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-92327872022-06-27 HPR31 Impact of Telehealth Use during the COVID-19 Pandemic on Glycemic Control and Other Biomarkers Among Type 2 Diabetes Patients Shao, Y Shi, L Nauman, E Price-Haywood, E Stoecker, C Value Health Article Published by Elsevier Inc. 2022-07 2022-06-25 /pmc/articles/PMC9232787/ http://dx.doi.org/10.1016/j.jval.2022.04.957 Text en Copyright © 2022 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Shao, Y
Shi, L
Nauman, E
Price-Haywood, E
Stoecker, C
HPR31 Impact of Telehealth Use during the COVID-19 Pandemic on Glycemic Control and Other Biomarkers Among Type 2 Diabetes Patients
title HPR31 Impact of Telehealth Use during the COVID-19 Pandemic on Glycemic Control and Other Biomarkers Among Type 2 Diabetes Patients
title_full HPR31 Impact of Telehealth Use during the COVID-19 Pandemic on Glycemic Control and Other Biomarkers Among Type 2 Diabetes Patients
title_fullStr HPR31 Impact of Telehealth Use during the COVID-19 Pandemic on Glycemic Control and Other Biomarkers Among Type 2 Diabetes Patients
title_full_unstemmed HPR31 Impact of Telehealth Use during the COVID-19 Pandemic on Glycemic Control and Other Biomarkers Among Type 2 Diabetes Patients
title_short HPR31 Impact of Telehealth Use during the COVID-19 Pandemic on Glycemic Control and Other Biomarkers Among Type 2 Diabetes Patients
title_sort hpr31 impact of telehealth use during the covid-19 pandemic on glycemic control and other biomarkers among type 2 diabetes patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232787/
http://dx.doi.org/10.1016/j.jval.2022.04.957
work_keys_str_mv AT shaoy hpr31impactoftelehealthuseduringthecovid19pandemiconglycemiccontrolandotherbiomarkersamongtype2diabetespatients
AT shil hpr31impactoftelehealthuseduringthecovid19pandemiconglycemiccontrolandotherbiomarkersamongtype2diabetespatients
AT naumane hpr31impactoftelehealthuseduringthecovid19pandemiconglycemiccontrolandotherbiomarkersamongtype2diabetespatients
AT pricehaywoode hpr31impactoftelehealthuseduringthecovid19pandemiconglycemiccontrolandotherbiomarkersamongtype2diabetespatients
AT stoeckerc hpr31impactoftelehealthuseduringthecovid19pandemiconglycemiccontrolandotherbiomarkersamongtype2diabetespatients

Ejemplares similares